Document Report Card
Basic Information
ID: ALA4665883
Journal: Bioorg Med Chem Lett
Title: Development of DHQ-based chemical biology probe to profile cellular targets for HBV.
Authors: Zhang Q,Huang J,Chow HY,Wang J,Zhang Y,Fung YME,Ren Q,Li X
Abstract: Chronic hepatitis B virus (HBV) infection has been a serious public health burden worldwide. Current anti-HBV therapies could not eliminate HBV ultimately. Considering the characteristics of HBV, it is impossible to be entirely cured based on current therapies. Therefore, it is urgently needed to develop novel therapeutic agents with new mechanism of action. The dihydroquinolizinone (DHQ) derivatives exhibited potent anti-HBV activity by decreasing HBV DNA and HBsAg level in an obscure mechanism of action. In this study, we have optimized the DHQ scaffold, developed the photoaffinity probe, with which to identify potential binding proteins.
CiteXplore: 33080351